Enterprise solutions for therapeutic development and discovery. Accelerate your pipeline with modular platforms designed for complex multi-target therapies.
Biotech and pharma companies face mounting pressure to deliver novel therapeutics faster and more cost-effectively
Most diseases involve multiple pathways and targets. Single-target approaches often fail in the clinic. You need tools to design and test multi-target therapies that address disease complexity from the start.
Traditional vector design and optimization extend preclinical timelines by many months. Each iteration requires extensive redesign and revalidation.
Current delivery methods cannot accommodate the large, complex genetic payloads needed for next-generation therapies. This forces compromises in therapeutic design and limits your ability to target multiple pathways simultaneously.
Identifying and validating biomarkers for patient stratification and response monitoring is slow and expensive. Limited tools for comprehensive omics integration delay your understanding of mechanism of action and therapeutic efficacy.
Bird of Prey empowers biotech and pharma to develop next-generation therapeutics with unprecedented speed and flexibility
Design sophisticated therapies that target multiple disease pathways simultaneously. Our modular & standardized platform enables you to combine complementary effectors, test synergistic mechanisms, and optimize multi-target combinations. Move beyond single-target limitations to address the full complexity of disease biology.
Gain precise temporal control over therapeutic expression with our suite of inducible systems. Test dose-dependent effects, optimize therapeutic windows, and develop safer, more controllable therapies. Perfect for investigating mechanism of action and managing potential toxicity in preclinical models.
Integrate comprehensive omics data to identify and validate biomarkers faster. Our reporter modules and multi-target capabilities enable systematic exploration of therapeutic response mechanisms. Accelerate patient stratification strategies and companion diagnostic development from the earliest stages.
Break free from payload limitations with our purpose-built shuttle vectors. Deliver large, complex genetic constructs that were previously impossible. Design ambitious therapies with multiple effectors, comprehensive regulatory elements, and sophisticated control mechanisms all in a single vector.
Navigate the complexity of modular vector design with our intelligent AI assistant. Get personalized recommendations for module combinations, optimize your therapeutic strategy, and accelerate decision-making with data-driven insights. Our AI learns from your program goals to suggest optimal configurations and flag potential design issues early.
A strategic partnership model designed for biotech and pharmaceutical innovation
We dive deep into your therapeutic program goals, disease biology, and pipeline priorities. Our team helps map out modular strategies for your key assets and identifies opportunities for multi-target approaches.
Access our module libraries or collaborate on custom component development for your specific therapeutic needs. We provide exclusive access to proprietary modules and can co-develop novel effectors tailored to your targets.
As your lead programs advance, leverage the platform for next-generation assets and pipeline expansion. We continue to evolve our technology based on your feedback and emerging therapeutic opportunities.
Commercial access to our modular platform for therapeutic development
Partner on novel module development and share in the value of breakthrough innovations
Dedicated scientific and technical support throughout your development journey